Search - tctmd.com

Displaying 1 - 7 of 7

Sort: Relevancy | Date

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

December 17, 2018

Three-Year Clinical Outcome after Angioplasty for Critical Limb Ischemia in Japanese Hemodialysis Patients

Presentation TCT Abstracts Posters 2018

Three-Year Clinical Outcome after Angioplasty for Critical Limb Ischemia in Japanese Hemodialysis Patients

Presenter: Yoshitaka Shiratori

September 25, 2018

Patients on hemodialysis undergoing TAVR: clinical outcome of 42 consecutive patients from a single center cohort

Presentation TCT Abstracts Posters 2018

Patients on hemodialysis undergoing TAVR: clinical outcome of 42 consecutive patients from a single center cohort

Presenter: H. Ruge

September 25, 2018

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Presentation TCT Abstracts Posters 2018

Impact of HDL to major adverse limb event in end-stage renal disease on hemodialysis due to diabetic nephropathy. from PREDICT study

Presenter: Tamon Kato

September 25, 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

News Conference News ACC 2018

Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS

Michael O'Riordan

March 12, 2018

PCI via Ulnar Artery Equally as Safe and Effective as Transradial Approach

News Daily News

PCI via Ulnar Artery Equally as Safe and Effective as Transradial Approach

Michael O'Riordan

February 09, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.